Leukotriene Antagonists: Clinical Trials

11 trials of Leukotriene Antagonists, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

8 completed, 3 unknown. 4 Not applicable, 3 Phase 4, 2 Phase 3, 1 Early Phase 1.

By phase and status

PhaseTrialsStatus
Not applicable4Completed 4
Phase 43Completed 2, Unknown 1
Phase 32Completed 1, Unknown 1
Early Phase 11Unknown 1

Follow Leukotriene Antagonists: new trials by email Literature Review of Leukotriene Antagonists trials Research Report on Leukotriene Antagonists

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Real-world Evaluation of the Effectiveness of Immunoglobulin-Histamine Complex, IHC (Histoglob) in Chronic Urticaria
Antihistaminics, H2 blockers, Leukotriene antagonists, Immunoglobulin/Histamine Complex (IHC) Injection - Chronic Urticaria
CompletedBharat Serums and Vaccines Limited6602025-12-312026-10-02
Prospective Multicenter Observational Study and Promotion of the Application of Focused Ultrasound in Allergic Rhinitis
High-intensity focused ultrasound (HIFU), intranasal corticosteroids, oral antihistamines, oral leukotriene receptor antagonists, and intranasal antihistamines - Allergic Rhinitis
Early Phase 1UnknownChongqing Medical University2402023-08-012024-02-22
The Efficacy of Leukotriene Inhibitor in Adult Patients With Moderate SARS-COV-2 Symptoms (COVID19)
Leukotriene Receptor Antagonist, Placebo - Moderate Covid19
Phase 3UnknownKing Abdullah International Medical Research Center662021-02-282021-05-10
Experienced Chinese Herbal Formulas on Pediatric Asthma
experienced chinese herbal formulas, leukotriene receptor antagonist and bronchial relaxant - Childhood Asthma
Not applicableCompletedChildren's Hospital of Fudan University1822013-03-012015-08-11
Role of Leukotriene Receptor Antagonists in Treatment of Chronic Periodontitis
Montelukast, Placebo - Chronic Periodontitis
Phase 4CompletedTatyasaheb Kore Dental College602012-03-012013-12-19
A Safety Study of Xolair (Omalizumab) in Patients With Chronic Idiopathic Urticaria (CIU) Who Remain Symptomatic Despite Treatment With H1 Antihistamines, H2 Blockers, and/or Leukotriene Receptor Antagonists
Omalizumab, Placebo, H1 antihistamine, H2 antihistamine, leukotriene receptor antagonist - Chronic Idiopathic Urticaria
Phase 3CompletedGenentech, Inc.3362011-02-012013-11-26
Leukotriene D4 Bronchial Provocation Test (LTD4-BPT) as an Indicator for the Use of Leukotriene Receptor Antagonist (LTRA)
leukotriene receptor antagonist (montelukast) - Bronchial Asthma
Not applicableCompletedGuangzhou Institute of Respiratory Disease322010-03-012011-08-18
Montelukast in Children With Wheezing
Montelukast - Wheezing
Phase 4UnknownUniversita di Verona402009-09-012013-06-19
Beneficial Effects of Lactobacillus Reuteri DSM 17938 Supplementation on Asthmatic Children
Antileukotrienes + Lactobacillus reuteri, Antileukotrienes + Placebo - Airways Allergic Inflammation of Asthmatic Children
Not applicableCompletedFederico II University502009-06-012011-10-03
The Effects of Montelukast on Smokers With Asthma
Fluticasone Propionate, Montelukast, Salmeterol - Asthmatic Smokers, Non-asthmatic Smokers
Phase 4CompletedInje University1052007-02-012012-05-16
Childhood Asthma Research and Education (CARE) Network Trial - Acute Intervention Management Strategies (AIMS)
Inhaled Corticosteroid (Budesonide), Leukotriene Receptor Antagonist (Montelukast Sodium), Inhaled Albuterol - Asthma, Lung Diseases
Not applicableCompletedNational Heart, Lung, and Blood Institute (NHLBI)2382004-02-012016-07-29

Conditions studied

Asthma (3)  ·  Chronic Urticaria (2)  ·  Respiratory Sounds (2)  ·  Chronic Periodontitis (1)  ·  Lung Diseases (1)  ·  Rhinitis, Allergic (1)  ·  Urticaria (1)

Sponsors

Bharat Serums and Vaccines Limited (1)  ·  Children's Hospital of Fudan University (1)  ·  Chongqing Medical University (1)  ·  Federico II University (1)  ·  Genentech, Inc. (1)  ·  Guangzhou Institute of Respiratory Disease (1)  ·  Inje University (1)  ·  King Abdullah International Medical Research Center (1)  ·  National Heart, Lung, and Blood Institute (NHLBI) (1)  ·  Tatyasaheb Kore Dental College (1)  ·  Universita di Verona (1)

Countries

China (3)  ·  India (2)  ·  Italy (2)  ·  United States (2)  ·  Australia (1)  ·  Germany (1)  ·  New Zealand (1)  ·  Poland (1)  ·  Saudi Arabia (1)  ·  Singapore (1)  ·  South Korea (1)  ·  Switzerland (1)  ·  United Kingdom (1)

Top investigators

Attilio L Boner, MD (1)  ·  Chang-Keun Kim, MD, PhD (1)  ·  Dr Saswata Banerjee (1)  ·  Edward R. Conner, M.D. (1)  ·  Michele Miraglia del Giudice, MD (1)  ·  Saurabh P Inamdar, BDS (1)  ·  Shen Yang, Doctoral (1)  ·  Vernon M. Chinchilli, PhD (1)

Results publications

PMID 18973936, PMID 24506412, PMID 26054553, PMID 27424128, PMID 27540466, PMID 27939380, PMID 28390587, PMID 29655772, PMID 36738927

NIH funding

U10HL064287 (1), U10HL064288 (1), U10HL064295 (1), U10HL064305 (1), U10HL064307 (1), U10HL064313 (1)